NCT00820976View on ClinicalTrials.gov

Induction With or Without Granulocyte Colony-Stimulating Factor in AML Transplantation in AML

PHASE3CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

March 31, 1996

Primary Completion Date

March 31, 2000

Study Completion Date

January 31, 2009

Conditions
AML
Interventions
DRUG

G-CSF

Filgrastim(5 µg/kg intravenously over 30 minutes ) was administered starting from day 8 until neutrophil recovery

All Listed Sponsors
lead

Turkish Leukemia Study Group

OTHER